Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy Clinical Trials in Boston, Massachusetts

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy